U.S. Markets close in 40 mins

Gilead shares up after FDA approves breakthrough cancer treatment

The FDA has approved a new cancer treatment developed by Gilead's $11B acquisition Kite Pharma. Yahoo Finance’s Alexis Christoforous, Rick Newman, and Nicole Sinclair have more.